The Role of Interleukin-1 Beta and Interleukin 8 in Acne Pathogenesis: A Serum-Based Severity Assessment
DOI:
https://doi.org/10.32007/jfacmedbaghdad3179Keywords:
Acne Vulgaris, Biomarkers, Interleukin-1 beta, Interleukin-8, PrognosisAbstract
Received: July 2025
Revised: Nov. 2025
Accepted: Dec. 2025
Published Online: Dec. 2025
Background: Acne vulgaris (AV) is a skin disorder affecting both sexes, starting at adolescence, and might continue into late adulthood. It is represented by a flare-up of nodular and postural lesions. Acne vulgaris patients with severe presentation suffer the consequences of skin scarring and disfigurement. Both Interleukin 1 beta (IL-1β) and Interleukin 8 (IL-8) are pro-inflammatory cytokines that play a significant role in acne pathogenesis and disease progression.
Objectives: To assess the serum level of interleukin 1 beta and interleukin 8 in acne patients and see how it correlates with the severity of the disease.
Methods: It was a case–control study conducted from October 2024 to March 2025, with 60 acne vulgaris patients divided into two groups, mild and severe, with ages ranging from 14 to 25 years. The patients were seen in the Dermatology Center, Baghdad Teaching Hospital, The Medical City Complex, Baghdad, Iraq. Thirty healthy individuals of both sexes of similar age groups to the patients were recruited as controls in this study. A detailed history was taken, and clinical examination was performed on all the participants. For each participant, IL-1β and IL-8 were measured using the Enzyme‑Linked Immunosorbent Assay method and the results were statistically analyzed and tabulated.
Results: The difference between the control and patient groups in regard to IL-1β and the difference between the patient groups themselves were not significant. Regarding IL-8, there was a significant difference between the control and patient groups and between the control and severe groups, while the difference between patient groups was highly significant.
Conclusion: Blood quantification of Interleukin 8 proved useful in trying to assess the severity of acne vulgaris, while serum Interleukin 1 beta levels proved to be of no value in assessing the severity of Acne vulgaris.
Received: July 2025
Revised: Nov. 2025
Accepted: Dec. 2025
Published Online: Dec. 2025
References
. Zhao T, Zha Y, Jiang S, Wang R, Song Y, Li L, et al. Temporin-GHa derived peptide shows inhibitory efficacy against Cutibacterium acnes and alleviates inflammatory reactions in acne vulgaris. International Immunopharmacology. 2025 Jun 5; 157:114756. https://doi.org/10.1016/j.intimp.2025.114756
2. Koç Ha, Güney Ca, Önal Bs. Attention Deficit Hyperactivity Disorder and Treatment Adherence in Adolescent Acne Patients: Investigating the Relationship for Better Care Strategies. Dermatology Practical & Conceptual. 2025 Jan 30;15(1):4854. https://doi.org/10.5826/dpc.1501a4854
3. El Kazzi T, Shahine M, Salameh P. Effect of severity of acne on the mental health of Lebanese patients with acne: findings from an online survey. BMC psychology. 2025 May 13;13(1):502. https://doi.org/10.1186/s40359-025-02808-8
4. Arpa Md, Biltekin Kaleli Sn, Doğan N. Hydroxypropyl-Β-Cyclodextrin-Enhanced Azelaic Acid Hydrogel for Acne Treatment: Evaluation of Antimicrobial, Anti-Inflammatory, and Skin Penetration Properties. J Pharm Innov. 2025 Jun;20(3):106.
https://doi.org/10.1007/s12247-025-10020-9
5. AlEdani EM, Ashour Y. All About Acne Vulgaris and Adolescent Acne Plus Its Mechanism. In Nutrition and Acne Vulgaris: A Concise Guide to the Effects of Diet on Adolescent and Adult Acne 2025 Apr 25 (pp. 1-30). Cham: Springer Nature Switzerland.
https://doi.org/10.1007/978-3-031-83677-01
6. Cordiano R, Caserta S, Minciullo Pl, Allegra A, Gangemi S. Anthraquinones and Aloe Vera Extracts as Potential Modulators of Inflammaging Mechanisms: A Translational Approach from Autoimmune to Onco-Hematological Diseases. Molecules. 2025 Mar 11;30(6):1251. https://doi.org/10.3390/molecules30061251
7. Firlej E, Kowalska W, Szymaszek K, Roliński J, Bartosińska J. The Role of Skin Immune System in Acne. Journal of Clinical Medicine. 2022 Mar 13;11(6):1579. https://doi.org/10.3390/jcm11061579
8. Mohamed M, Shehata Ha, Fahmy Nf, Saleh R. Evaluation of serum levels of interleukins 1‐beta, 10 and 12 in patients with acne vulgaris. J. Cosmet. Dermatol. 2022 Dec;21(12):7100-6. https://doi.org/10.1111/jocd.15399
9. Singh S, Khurana A, Chitkara A. Evaluation of Serum Levels of Interleukins 6, 8, 17 and 22 in Acne Vulgaris: A Cross-Sectional Study. Indian J Dermat. 2023 Mar 1;68(2):233. https://doi.org/10.4103/ijd.ijd_786_21
10. Vilotić A, Nacka-Aleksić M, Pirković A, Bojić-Trbojević Ž, Dekanski D, Jovanović Krivokuća M. Il-6 and Il-8: An Overview of Their Roles in Healthy and Pathological Pregnancies. Int. J. Mol. Sci. 2022 Nov 23;23(23):14574. https://doi.org/10.3390/ijms232314574
11. Marcinkiewicz M, Majewski S. The role of antimicrobial peptides in chronic inflammatory Sskin diseases. Advances in Dermatology and Allergology/Postępy Dermatologii I Alergologii. 2016 Feb 29;33(1):6; https://doi.org/10.5114/pdia.2015.48066
12. Campbell Dj, Kim Ch, Butcher Ec. Chemokines in the systemic organization of immunity. Immunological Reviews. 2003 Oct;195(1):58-71. https://doi.org/10.1034/j.1600-065X.2003.00067.x
13. Li L, Li J, Gao M, Fan H, Wang Y, Xu X, Et al. Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients. Frontiers in Immunology. 2021 Jan 8; 11:602395. https://doi.org/10.3389/fimmu.2020.602395
14. Murphy, K., & Weaver, C. Janeway immunoologie (9th Ed.). Springer-Verlag; 2018 Jul 4. https://doi.org/10.1007/978-3-662-56004-4
15. Bernales Salinas A. Acne vulgaris: role of the immune system. Int. J. Dermatol. 2021 Sep;60(9):1076-81. https://doi.Org/10.1111/ijd.15415
16. Marcuzzi A, Melloni E, Zauli G, Romani A, Secchiero P, Maximova N, Et al. Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptive Immunity. Int J Mol Sci. 2021 Oct 18;22(20):11241. https://doi.org/10.3390/ijms222011241
17. Riihilä P, Nissinen L, Kähäri Vm. Matrix metalloproteinases in keratinocyte carcinomas. Experimental dermatology. 2021 Jan;30(1):50-61. https://doi.org/10.1111/exd.14183
18. Jahns Ac, Eilers H, Ganceviciene R, Alexeyev Oa. Propionibacterium species and follicular keratinocyte activation in acneic and normal skin. British Journal of Dermatology. 2015 Apr 1;172(4):981-7. https://doi.org/10.1111/bjd.13436
19. Sibero HT, Darwin E, Wirasati Y, Yenny SW, Suharmanto S. The Difference in Interleukin-8 (Il-8) on Degrees of Acne Vulgaris Severity. Indian J. Med. Forensic Med. Toxicol [Internet]. 2021 May 17 [Cited 2025 Dec. 22];15(3):3207-12. https://doi.org/10.37506/ijfmt.v15i3.15798
20. Teichert T, Vossoughi M, Vierkötter A, Sugiri D, Schikowski T, Hoffmann B, Et al. Investigating the spill-Over hypothesis: Analysis of the association between local inflammatory markers in sputum and systemic inflammatory mediators in plasma. Environmental research. 2014 Oct 1; 134:24-32. https://doi.org/10.1016/j.envres.2014.06.021
21. Dinarello Ca. Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist. International Reviews of Immunology. 1998 Jan 1;16(5-6):457-99. https://doi.org/10.3109/08830189809043005
22. Narros‐Fernández P, Chomanahalli Basavarajappa S, Walsh PT. Interleukin‐1 family cytokines at the crossroads of microbiome regulation in barrier health and disease. The FEBS Journal [Internet]. 2024 May ;291(9):1849-69. https://doi.org/10.1111/febs.16888
23. Anh Lv, Giang Th, Hung Tq, Trung Vt, Vuong Nl. Immunohistochemical expression of interleukin 1 beta in papule biopsies from patients with acne vulgaris. Dermatology Reports. 2022 Mar 17;14(3):9444. https://doi.org/10.4081/dr.2022.9444
24. Elattar Y, Mourad B, Alngomy Ha, Shams El Deen A, Ismail M. Study of interleukin‐1 beta expression in acne vulgaris and acne scars. J. Cosmet. Dermatol. 2022 Oct;21(10):4864-70. https://doi.org/10.1111/jocd.14852
Downloads
License
Copyright (c) 2025 Ihsan W. AL-Husseinawi, Haifaa S. Al-Hadithi, Adil A. Noaimi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution 4.0 International license..
